Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

665 ARTÍCULOS , VIENDO DEL 211 AL 225

A critical review on the role of nanotheranostics mediated approaches for targeting β amyloid in Alzheimer's

Rastogi V, Jain A, Kumar P, Yadav P, Porwal M, Chaturvedi S, Chandra P, Verma A.

J Drug Target. 2023 Aug;31(7):725-744. doi: 10.1080/1061186X.2023.2238250. Epub 2023 Jul 19.

Exploring New Vista for Alzheimer's Disease Drug Targets (Part II)

Bolinger AA, Zhou J.

Curr Top Med Chem. 2023;23(13):1211-1213. doi: 10.2174/156802662313230626121232.

Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action

Sidiropoulou GA, Metaxas A, Kourti M.

Front Endocrinol (Lausanne). 2023 Jul 3;14:1217730. doi: 10.3389/fendo.2023.1217730. eCollection 2023.

Targeted Regulation of Intracellular Signal Transduction: A New Paradigm for Stimulation of Neurogenesis in Alzheimer's Disease

Zyuz'kov G.

Curr Drug Targets. 2023;24(10):777-780. doi: 10.2174/1389450124666230719104808.

Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease

Sato K, Takayama KI, Inoue S.

Front Endocrinol (Lausanne). 2023 Jul 4;14:1220150. doi: 10.3389/fendo.2023.1220150. eCollection 2023.

Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer's Disease

Leisher S, Bohorquez A, Gay M, Garcia V, Jones R, Baldaranov D, Rafii MS.

CNS Drugs. 2023 Aug;37(8):671-677. doi: 10.1007/s40263-023-01021-8. Epub 2023 Jul 20.

The aquaporin-4 water channel and updates on its potential as a drug target for Alzheimer's disease

Silverglate B, Gao X, Lee HP, Maliha P, Grossberg GT.

Expert Opin Ther Targets. 2023 Jul-Dec;27(7):523-530. doi: 10.1080/14728222.2023.2240017. Epub 2023 Jul 27.

Patent analysis of novel therapeutic approaches for treating Alzheimer's disease 2018-2023

Saleem F, Naz F, Khan KM.

Pharm Pat Anal. 2023 May;12(3):91-94. doi: 10.4155/ppa-2023-0020. Epub 2023 Jul 21.

Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in Alzheimer's Disease Brain Pathology Exacerbated by Sleep Deprivation

Sharma A, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD, Nozari A, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS.

Adv Neurobiol. 2023;32:3-53. doi: 10.1007/978-3-031-32997-5_1.

Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer's Disease Exacerbated by Concussive Head Injury

Sharma HS, Muresanu DF, Nozari A, Lafuente JV, Buzoianu AD, Tian ZR, Huang H, Feng L, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma A.

Adv Neurobiol. 2023;32:139-192. doi: 10.1007/978-3-031-32997-5_4.

Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective

Li X, Quan M, Wei Y, Wang W, Xu L, Wang Q, Jia J.

Sci China Life Sci. 2023 Dec;66(12):2711-2754. doi: 10.1007/s11427-022-2357-x. Epub 2023 Jul 17.

Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update

Yadollahikhales G, Rojas JC.

Neurotherapeutics. 2023 Jul;20(4):914-931. doi: 10.1007/s13311-023-01405-0. Epub 2023 Jul 25.

The roles of natural triterpenoid saponins against Alzheimer's disease

Zhou JC, Li HL, Zhou Y, Li XT, Yang ZY, Tohda C, Komatsu K, Piao XH, Ge YW.

Phytother Res. 2023 Nov;37(11):5017-5040. doi: 10.1002/ptr.7967. Epub 2023 Jul 25.

Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology

Ramanan VK, Armstrong MJ, Choudhury P, Coerver KA, Hamilton RH, Klein BC, Wolk DA, Wessels SR, Jones LK Jr; AAN Quality Committee.

Neurology. 2023 Nov 7;101(19):842-852. doi: 10.1212/WNL.0000000000207757. Epub 2023 Jul 26.

Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview

Catumbela CSG, Giridharan VV, Barichello T, Morales R.

Transl Neurodegener. 2023 Jul 26;12(1):37. doi: 10.1186/s40035-023-00369-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias